MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system
暂无分享,去创建一个
[1] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.
[2] R I Grossman,et al. Magnetization transfer in multiple sclerosis , 1994, Annals of neurology.
[3] A. Thompson,et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.
[4] R I Grossman,et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. , 1995, Radiology.
[5] M Filippi,et al. A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.
[6] David H. Miller,et al. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance , 1996, Magnetic resonance in medicine.
[7] S. Rombouts,et al. Visual activation patterns in patients with optic neuritis , 1998, Neurology.
[8] R I Grossman,et al. Total brain N‐acetylaspartate concentration in normal, age‐grouped females: Quantitation with non‐echo proton NMR spectroscopy , 1998, Magnetic resonance in medicine.
[9] J K Udupa,et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS , 1998, Neurology.
[10] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[11] P M Matthews,et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.
[12] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[13] M Rovaris,et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis , 1998, Neurology.
[14] A. Compston,et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis , 1999, Annals of neurology.
[15] G. Barker,et al. Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H , 1999, Neurology.
[16] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.
[17] M Rovaris,et al. Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. , 1999, Current opinion in neurology.
[18] G. Barker,et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis , 1999, Neurology.
[19] R. Tarducci,et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. , 1999, Brain : a journal of neurology.
[20] G J Barker,et al. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. , 1999, Magnetic resonance imaging.
[21] M Filippi,et al. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms , 1999, Journal of the Neurological Sciences.
[22] D. Li,et al. Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. , 1999, Annals of neurology.
[23] M Filippi,et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI , 1999, Neurology.
[24] D. Paty,et al. Magnetic resonance imaging results of the PRISMS trial: A randomized, double‐blind, placebo‐controlled study of interferon‐β1a in relapsing‐remitting multiple sclerosis , 1999 .
[25] M Filippi,et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS , 2000, Neurology.
[26] P. C. de Freitas Mathias,et al. Insulin Secretion and Acetylcholinesterase Activity in Monosodium L-Glutamate-Induced Obese Mice , 2001, Hormone Research in Paediatrics.
[27] G. Comi,et al. Magnetization transfer imaging to monitor the evolution of MS , 2000, Neurology.
[28] E. Cabanis,et al. [Magnetic resonance spectroscopy in multiple sclerosis]. , 2000, Revue neurologique.
[29] M Filippi,et al. Cladribine and progressive MS , 2000, Neurology.
[30] M S Buchsbaum,et al. Whole-brain diffusion MR histograms differ between MS subtypes , 2000, Neurology.
[31] P M Matthews,et al. Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. , 2000, Archives of neurology.
[32] G. Comi,et al. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI , 2000, Neurology.
[33] G. B. Pike,et al. Relating axonal injury to functional recovery in MS , 2000, Neurology.
[34] R I Grossman,et al. Total brain N-acetylaspartate , 2000, Neurology.
[35] M Rovaris,et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.
[36] G J Barker,et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. , 2000, Brain : a journal of neurology.
[37] P M Matthews,et al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis , 2000, Annals of neurology.
[38] M Rovaris,et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.
[39] C Caltagirone,et al. Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. , 2000, AJNR. American journal of neuroradiology.
[40] M W Weiner,et al. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS , 2000, Multiple sclerosis.
[41] P M Matthews,et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. , 2000, Brain : a journal of neurology.
[42] M Rovaris,et al. Whole brain volume changes in patients with progressive MS treated with cladribine , 2000, Neurology.
[43] Ludwin Sk,et al. The neuropathology of multiple sclerosis. , 2000 .
[44] M Cercignani,et al. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. , 2000, Archives of neurology.
[45] G. Comi,et al. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. , 2000, AJNR. American journal of neuroradiology.
[46] G J Barker,et al. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study , 2000, Journal of neurology, neurosurgery, and psychiatry.
[47] M Cercignani,et al. Weekly diffusion-weighted imaging of normal-appearing white matter in MS , 2000, Neurology.
[48] Nikos Evangelou,et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.
[49] G J Barker,et al. The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. , 2000, Brain : a journal of neurology.
[50] F. Barkhof,et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy , 2001, Journal of the Neurological Sciences.
[51] J. Dehmeshki,et al. Analysis of MTR histograms in multiple sclerosis using principal components and multiple discriminant analysis , 2001, Magnetic resonance in medicine.
[52] Peter Kapeller,et al. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study , 2001, Journal of Neurology.
[53] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[54] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[55] M. Filippi,et al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS , 2001, Neurology.
[56] Marco Rovaris,et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.
[57] J S Wolinsky,et al. Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging , 2001, Multiple sclerosis.
[58] M Cercignani,et al. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[59] M Rovaris,et al. Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. , 2001, Brain : a journal of neurology.
[60] L. Kappos,et al. Clinical–MRI correlations in a European trial of interferon beta-1b in secondary progressive MS , 2001, Neurology.
[61] Massimo Filippi,et al. European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , 2001, Annals of neurology.
[62] Olga Ciccarelli,et al. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis , 2001, Multiple sclerosis.
[63] G J Barker,et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations , 2001, Neurology.
[64] G. Comi,et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[65] J K Udupa,et al. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[66] R. Kinkel,et al. Axonal loss in normal-appearing white matter in a patient with acute MS , 2001, Neurology.
[67] M Cercignani,et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis , 2001, Neurology.
[68] G. Comi,et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. , 2001, Brain : a journal of neurology.
[69] Massimo Filippi,et al. Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis , 2001, Journal of the Neurological Sciences.
[70] M Rovaris,et al. Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. , 2001, AJNR. American journal of neuroradiology.
[71] P M Matthews,et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.
[72] M. Filippi,et al. Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage , 2002, Annals of neurology.
[73] Jayaram K. Udupa,et al. Magnetization Transfer Ratio Histogram Analysis of Normal-Appearing Gray Matter and Normal-Appearing White Matter in Multiple Sclerosis , 2002, Journal of computer assisted tomography.
[74] S. Golaszewski,et al. Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. , 2002, Brain : a journal of neurology.
[75] Massimo Filippi,et al. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. , 2002, AJNR. American journal of neuroradiology.
[76] R. Tarducci,et al. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. , 2002, Journal of neurology.
[77] Massimo Filippi,et al. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. , 2002, Archives of neurology.
[78] P. Matthews,et al. Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.
[79] M. Rovaris,et al. Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging , 2002, Journal of the Neurological Sciences.
[80] Oded Gonen,et al. Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. , 2002, AJNR. American journal of neuroradiology.
[81] P Kapeller,et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[82] Marco Rovaris,et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. , 2002, Archives of neurology.
[83] David H. Miller,et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.
[84] Antonio Federico,et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. , 2002, Archives of neurology.
[85] M. Filippi,et al. Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study , 2002, Journal of the Neurological Sciences.
[86] Carlo Pozzilli,et al. A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. , 2002, Magnetic resonance imaging.
[87] Zografos Caramanos,et al. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis , 2002, Journal of Neurology.
[88] G. Scotti,et al. Functional Magnetic Resonance Imaging Correlates of Fatigue in Multiple Sclerosis , 2002, NeuroImage.
[89] Gian Domenico Iannetti,et al. Cortical motor reorganization after a single clinical attack of multiple sclerosis. , 2002, Brain : a journal of neurology.
[90] P M Matthews,et al. Evidence for widespread movement-associated functional MRI changes in patients with PPMS , 2002, Neurology.
[91] Gian Domenico Iannetti,et al. Contribution of Corticospinal Tract Damage to Cortical Motor Reorganization after a Single Clinical Attack of Multiple Sclerosis , 2002, NeuroImage.
[92] P M Matthews,et al. Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. , 2002, Brain : a journal of neurology.
[93] A. Thompson,et al. Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis , 2002, Multiple sclerosis.
[94] M. Filippi,et al. Correlations between Structural CNS Damage and Functional MRI Changes in Primary Progressive MS , 2002, NeuroImage.
[95] G. Barker,et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS , 2002, Neurology.
[96] M Rovaris,et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. , 2003, Brain : a journal of neurology.
[97] P. Morgan,et al. Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability , 2003, Journal of neurology, neurosurgery, and psychiatry.
[98] Stephen Smith,et al. Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. , 2003, Brain : a journal of neurology.
[99] Massimo Filippi,et al. Disturbed function and plasticity in multiple sclerosis as gleaned from functional magnetic resonance imaging. , 2003, Current opinion in neurology.
[100] M. Filippi,et al. Cord damage elicits brain functional reorganization after a single episode of myelitis , 2003, Neurology.
[101] J. Dehmeshki,et al. The normal appearing grey matter in primary progressive multiple sclerosis , 2003, Journal of Neurology.
[102] B M Bly,et al. An Investigation of Working Memory Rehearsal in Multiple Sclerosis Using fMRI , 2003, Journal of clinical and experimental neuropsychology.
[103] Adolf Pfefferbaum,et al. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. , 2003, AJNR. American journal of neuroradiology.
[104] G J Barker,et al. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities , 2003, Multiple sclerosis.
[105] Giuseppe Scotti,et al. Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis , 2003, NeuroImage.
[106] Giuseppe Scotti,et al. Functional cortical changes in patients with multiple sclerosis and nonspecific findings on conventional magnetic resonance imaging scans of the brain , 2003, NeuroImage.
[107] Gareth J. Barker,et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging , 2003, Journal of Neurology.
[108] Oded Gonen,et al. Diffusely elevated cerebral choline and creatine in relapsing‐remitting multiple sclerosis , 2003, Magnetic resonance in medicine.
[109] J. Babb,et al. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. , 2003, AJNR. American journal of neuroradiology.
[110] Giuseppe Scotti,et al. A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis , 2003, NeuroImage.
[111] P. Jezzard,et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis , 2003, Neurology.
[112] Marco Rovaris,et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. , 2003, Brain : a journal of neurology.
[113] Rohit Bakshi,et al. Thalamic Involvement in Multiple Sclerosis: A Diffusion‐Weighted Magnetic Resonance Imaging Study , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[114] My-Van Au Duong,et al. Voxel‐based analysis of MTR images: A method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis , 2004, Journal of magnetic resonance imaging : JMRI.
[115] Marco Rovaris,et al. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial , 2004, The Lancet.
[116] Christian M Kerskens,et al. Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study , 2004, Multiple sclerosis.
[117] Giuseppe Scotti,et al. Pyramidal tract lesions and movement-associated cortical recruitment in patients with MS , 2004, NeuroImage.
[118] M. Filippi,et al. A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early-onset multiple sclerosis. , 2004, Archives of neurology.
[119] Massimo Filippi,et al. Indirect evidence for early widespread gray matter involvement in relapsing–remitting multiple sclerosis , 2004, NeuroImage.
[120] D. Arnold,et al. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. , 2004, Archives of neurology.
[121] M. Filippi,et al. Simple and complex movement‐associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis , 2004, Human brain mapping.
[122] Giuseppe Scotti,et al. A functional MRI study of cortical activations associated with object manipulation in patients with MS , 2004, NeuroImage.
[123] L. Martí-Bonmatí,et al. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis. , 2004, Brain : a journal of neurology.
[124] G. Comi,et al. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[125] Caterina Mainero,et al. fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis , 2004, NeuroImage.
[126] M. Filippi,et al. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis , 2005, Journal of the Neurological Sciences.
[127] Marco Rovaris,et al. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI , 2005, NeuroImage.
[128] Marco Rovaris,et al. Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients , 2005, NeuroImage.
[129] Marco Rovaris,et al. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. , 2005, Archives of neurology.
[130] Marco Rovaris,et al. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. , 2005, Archives of neurology.
[131] Maria Assunta Rocca,et al. A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis , 2005, NeuroImage.
[132] M. Filippi,et al. A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. , 2005, AJNR. American journal of neuroradiology.
[133] M. Rovaris,et al. Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. , 2005, Archives of neurology.